0001877589-22-000006.txt : 20221021 0001877589-22-000006.hdr.sgml : 20221021 20221021193550 ACCESSION NUMBER: 0001877589-22-000006 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220920 FILED AS OF DATE: 20221021 DATE AS OF CHANGE: 20221021 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Samaha Eli CENTRAL INDEX KEY: 0001877589 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36033 FILM NUMBER: 221324629 MAIL ADDRESS: STREET 1: ONE WORLD TRADE CENTER STREET 2: FLOOR 65 CITY: NEW YORK STATE: NY ZIP: 10007 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Theravance Biopharma, Inc. CENTRAL INDEX KEY: 0001583107 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: UGLAND HOUSE, SOUTH CHURCH STREET CITY: GEORGE TOWN, GRAND CAYMAN STATE: E9 ZIP: KY1-1104 BUSINESS PHONE: 650-808-6000 MAIL ADDRESS: STREET 1: UGLAND HOUSE, SOUTH CHURCH STREET CITY: GEORGE TOWN, GRAND CAYMAN STATE: E9 ZIP: KY1-1104 3 1 primary_doc.xml PRIMARY DOCUMENT X0206 3 2022-09-20 0 0001583107 Theravance Biopharma, Inc. tbph 0001877589 Samaha Eli 150 EAST 58TH ST STE 1403 NEW YORK NY 10150 0 0 1 0 COM 7012226 I See footnote These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person in the funds. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial ownership of such securities. Eli Samaha 2022-10-21